This brochure provides an in-depth look at how our unique combination of specialized veterinary expertise, state-of-the-art facilities, and diverse NHP resources can accelerate client's drug development programs. It outlines our end-to-end capabilities, from custom disease model development and pharmacological profiling to regulatory-compliant toxicology and efficacy studies.

Key highlights covered in this brochure include:

Customized Non-Human Primate Models of Psychiatric Disorders

Leveraging cynomolgus and rhesus macaques (sharing ~95% genetic homology with humans), we develop customized models for complex CNS disorders such as autism, Alzheimer's disease, Parkinson's disease, epilepsy, and spinal cord injury. These models offer high phenotypic accuracy, thereby lowering translational risks.

Comprehensive Preclinical Services

Our integrated platform supports every stage of your program:

- Pharmacology & Efficacy: In vitro and in vivo screening for gene therapies, antibodies, and small molecules.

- Drug Metabolism & Safety: Comprehensive metabolism studies with specialized sample collection and metabolic cages.

- Behavioral & Imaging Assessments: Comprehensive metabolism studies with specialized sample collection and metabolic cages.

Biospecimen Collection & Analysis Services

To support downstream research, we provide high-quality NHP-derived products, including whole blood, serum, and hepatocytes (adherent or suspension) from specified macaques.

Uncompromising Animal Welfare & Compliance

Our facilities are internationally accredited, and all research strictly adheres to the 3R principles (Replacement, Reduction, Refinement). We prioritize animal well-being through enriched housing, expert veterinary care, and a dedicated behavioral health program, where scientific rigor and humane standards go hand in hand.

Expert Team & Flexible Collaboration

We offer flexible collaboration models ranging from project outsourcing and customized model development to technical consulting, to meet the specific research needs of diverse clients.

Whether you are advancing a novel biologic, evaluating a candidate compound, or seeking reliable translational models to de‑risk your pipeline, this brochure details how Ace Therapeutics can serve as a trusted partner in your psychiatric drug development journey.

Download the brochure to explore our full capabilities and discover how our NHP-based CRO solutions can accelerate your next breakthrough.

You might be interested in...